Singapore could allow therapeutic cloning for stem cell research
08 July, 2002 by Tanya HollisA Singapore government ethics committee has recommended in favour of therapeutic cloning in a move that could prove to be a research boon for private Australian company ES Cell International (ESI).
How Stem Cell Sciences tapped Japan's biobusiness bid
01 July, 2002 by Tanya HollisThe foundations for Japan's first stem cell company were laid in 1994 when two scientists from different countries met at an institute tens of thousands of kilometres from their respective homes.
Alzheimer's researcher wins Mayne Florey Medal
27 June, 2002 by Melissa TrudingerThe Australian Institute of Political Science has presented Prof Colin Masters with the 2002 Mayne Florey Medal, recognising his world-leading research into the cause of Alzheimer's disease and other brain diseases of the elderly.
We won't use ES cells: med institute
25 June, 2002 by Tanya HollisA children's research institute with a strong focus on gene therapy and stem cell work has declared it does not support human embryonic stem cell research.
Capillary Electrophoresis: complex technology for complex science
24 June, 2002 by Melissa TrudingerCapillary electrophoresis (CE) is a technique that allows researchers to separate analytes based on their differential mobilities in aqueous media when an electric field is applied.
Adult stem cell research adds fuel to local debate
21 June, 2002 by Tanya HollisNew research suggesting adult stem cells could be as flexible as embryonic stem cells has re-ignited debate over whether controversial Australian laws to permit research on human embryos should go ahead.
SCS establishes Japan's first stem cell company
20 June, 2002 by Tanya HollisMelbourne's Stem Cell Sciences (SCS) has added another block to its global network with the establishment of Japan's first stem cell company.
Monash research could lead to new thymus growth
17 June, 2002 by Melissa TrudingerScientists at Monash University have identified a population of epithelial cells in the thymus they hope will be able to regenerate and regrow the tiny immune system organ.
Chemeq chuffed by capital raising
11 June, 2002 by Melissa TrudingerChemeq has raised another $2.75 million as a result of a share purchase plan offered to its shareholders last month, bringing the total amount of funds raised recently to about $7.5 million.
Reeve, Colman to speak at conference
05 June, 2002 by Iain ScottActor Christopher Reeve, famous for his role as Superman before a horsing accident left him paralysed, will be one of the keynote speakers at a new conference on stem cells to be held in Melbourne in September.
BresaGen calls for more time on stem cell laws
05 June, 2002 by Melissa TrudingerStem cell company BresaGen has submitted a position paper to the drafting committee responsible for the forthcoming legislation for use of embryonic stem cells for creation of new stem cell lines for research and development.
HPLC market report: The smaller picture
04 June, 2002 by Melissa TrudingerThe big trend in liquid chromatography instrumentation is the ever-shrinking sample size, according to leading manufacturers of chromatographic instruments.
Now we're a global player: stem cell CEO
03 June, 2002 by Tanya HollisAustralia's decision to back stem cell research with a $46.5 million grant would have international ramifications for local researchers, according to the head of the winning Centre of Excellence bid.
Stem cell opponents shocked by funding decision
31 May, 2002 by Pete YoungOpponents of stem cell research taking part in consultative processes on draft legislation were shocked and surprised by the announcement that the Stem Cells and Tissue Repair consortium had won the Federal government's $46.5 million Centre of Excellence funding.
Stem cell bid wins $46.5m Centre of Excellence funding
31 May, 2002 by Iain ScottA proposal to create a Centre for Stem Cells and Tissue Repair has won a $46.5 million Federal grant to create a national Biotechnology Centre of Excellence.
